As biotech retreats, gene therapy companies retrench and redraw plans
March 24, 2022After Supreme Court win, Merck prevails against 500 Fosamax cases: report
March 24, 2022Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout
esagonowsky
Thu, 03/24/2022 – 11:38
